Rolf R. Engel

20.3k total citations · 4 hit papers
230 papers, 14.4k citations indexed

About

Rolf R. Engel is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Pharmacology. According to data from OpenAlex, Rolf R. Engel has authored 230 papers receiving a total of 14.4k indexed citations (citations by other indexed papers that have themselves been cited), including 113 papers in Psychiatry and Mental health, 47 papers in Cognitive Neuroscience and 42 papers in Pharmacology. Recurrent topics in Rolf R. Engel's work include Schizophrenia research and treatment (74 papers), Treatment of Major Depression (37 papers) and Bipolar Disorder and Treatment (30 papers). Rolf R. Engel is often cited by papers focused on Schizophrenia research and treatment (74 papers), Treatment of Major Depression (37 papers) and Bipolar Disorder and Treatment (30 papers). Rolf R. Engel collaborates with scholars based in Germany, United States and Switzerland. Rolf R. Engel's co-authors include Stefan Leucht, John M. Davis, Werner Kissling, Johannes Hamann, John M. Kane, Caroline Corves, Chunbo Li, S. Leucht, Josef Bäuml and Jamie Kane and has published in prestigious journals such as New England Journal of Medicine, The Lancet and The Journal of Experimental Medicine.

In The Last Decade

Rolf R. Engel

228 papers receiving 13.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

2013 1.8k citations Stefan Leucht, Rolf R. Engel et al. The Lancet profile →
Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

2008 1.4k citations Stefan Leucht, Caroline Corves et al. The Lancet profile →
What does the PANSS mean?

2005 926 citations Rolf R. Engel et al. profile →
Clinical implications of Brief Psychiatric Rating Scale scores

2005 683 citations Stefan Leucht, John M. Kane et al. profile →

Peers

Countries citing papers authored by Rolf R. Engel

Since Specialization

Citations

This map shows the geographic impact of Rolf R. Engel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rolf R. Engel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rolf R. Engel more than expected).

Fields of papers citing papers by Rolf R. Engel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rolf R. Engel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rolf R. Engel. The network helps show where Rolf R. Engel may publish in the future.

Co-authorship network of co-authors of Rolf R. Engel

This figure shows the co-authorship network connecting the top 25 collaborators of Rolf R. Engel. A scholar is included among the top collaborators of Rolf R. Engel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rolf R. Engel. Rolf R. Engel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Two Sides of Theory of Mind: Mental State Attribution to Moving Shapes in Paranoid Schizophrenia Is Independent of the Severity of Positive Symptoms 2024 ·Brain Sciences ·(unknown), Sarita Silveira, Thomas Meindl, Richard Musil, (unknown), (unknown), Norbert Müller, Hans‐Jürgen Möller, Rolf R. Engel, Maximilian F. Reiser, Martin Drießen, Thomas Beblo, Kristina Hennig‐Fast	3
2	Neurocognitive Deficits in First-Episode and Chronic Psychotic Disorders: A Systematic Review from 2009 to 2022 2023 ·Brain Sciences ·Nadja Tschentscher, (unknown), (unknown), (unknown), (unknown), Rolf R. Engel, Susanne Karch	12
3	Incidence of Drug-Induced Delirium During Treatment With Antidepressants or Antipsychotics: A Drug Surveillance Report of German-Speaking Countries Between 1993 and 2016 2022 ·The International Journal of Neuropsychopharmacology ·Michaela‐Elena Friedrich, R. Grohmann, Ulrich Rabl, Dietmar Winkler, Anastasios Konstantinidis, Rolf R. Engel, Johanna Seifert, Sermin Toto, Susanne Stübner, Richard Frey, Siegfried Kasper	7
4	Sex differences in pharmacological treatment of major depressive disorder: results from the AMSP pharmacovigilance program from 2001 to 2017 2021 ·Journal of Neural Transmission ·Johanna Seifert, (unknown), Matthias A. Reinhard, Rolf R. Engel, (unknown), Stefan Bleich, Susanne Stübner, Eckart Rüther, Sermin Toto, R. Grohmann, Marcel Sieberer, W. Greil	17
5	Time trends in pharmacological treatment of major depressive disorder: Results from the AMSP Pharmacovigilance Program from 2001–2017 2020 ·Journal of Affective Disorders ·Johanna Seifert, Rolf R. Engel, (unknown), (unknown), Stefan Bleich, Susanne Stübner, Marcel Sieberer, W. Greil, Sermin Toto, R. Grohmann	16
6	Efficacy of extended clinical management, group CBT, and group plus individual CBT for major depression: Results of a two-year follow-up study 2018 ·Journal of Affective Disorders ·Annette Schaub, (unknown), (unknown), Stephan Goerigk, Martin Hautzinger, (unknown), (unknown), Rolf R. Engel, Hans‐Jürgen Möller	8
7	Does Clinical Judgment of Baseline Severity and Changes in Psychopathology Depend on the Patient Population? 2010 ·Journal of Clinical Psychopharmacology ·Rebecca Schennach-Wolff, Michael Obermeier, Florian Seemüller, Markus Jäger, Max Schmauß, Gerd Laux, Herbert Pfeiffer, Dieter Naber, Lutz Schmidt, Wolfgang Gäebel, Joachim Klosterkötter, Isabella Heuser, Wolfgang Maier, Matthias Lemke, Eckart Rüther, Stefan Klingberg, Markus Gastpar, Rolf R. Engel, Hans‐Jürgen Möller, Michael Riedel	26
8	Second-generation versus first-generation antipsychotic drugs for schizophrenia : a meta-analysis. Commentary 2009 ·The Lancet ·Peter Tyrer, Timothy J. Kendall, Stefan Leucht, Caroline Corves, (unknown), Rolf R. Engel, Chunming Li, John M. Davis	2
9	The Impact of Homocysteine Levels on Cognition in Euthymic Bipolar Patients 2008 ·The Journal of Clinical Psychiatry ·(unknown), Florian Seemüller, Heinz Grunze, Markus Schwarz, J. Zach, Kristina Fast, Christoph Born, (unknown), Rolf R. Engel, (unknown), Hans‐Jürgen Möller, Michael Riedel, W. Emanuel Severus	39
10	Defining ‘Response’ in Antipsychotic Drug Trials: Recommendations for the Use of Scale-Derived Cutoffs 2007 ·Neuropsychopharmacology ·Stefan Leucht, John M. Davis, Rolf R. Engel, John M. Kane, Stefan Wagenpfeil	155
11	The dysbindin gene in major depression: An association study 2004 ·American Journal of Medical Genetics Part B Neuropsychiatric Genetics ·Peter Zill, Thomas C. Baghai, Rolf R. Engel, Peter Zwanzger, Cornelius Schüle, Daniela Eser, Stefanie Behrens, Rainer Rupprecht, Hans‐Jürgen Möller, Manfred Ackenheil, Brigitta Bondy	20
12	Association analysis of a polymorphism in the G‐protein stimulatory α subunit in patients with major depression* 2002 ·American Journal of Medical Genetics ·Peter Zill, Thomas C. Baghai, Peter Zwanzger, Cornelius Schüle, Christo Minov, Stefanie Behrens, Rainer Rupprecht, Hans‐Jürgen Möller, Rolf R. Engel, Brigitta Bondy	15
13	Amisulpride, an Unusual “Atypical” Antipsychotic: A Meta-Analysis of Randomized Controlled Trials 2002 ·American Journal of Psychiatry ·Stefan Leucht, Gabi Pitschel‐Walz, Rolf R. Engel, Werner Kissling	206
14	Lithium vs carbamazepine in the maintenance treatment of schizoaffective disorder: a randomised study 1997 ·European Archives of Psychiatry and Clinical Neuroscience ·W. Greil, Wolfgang Ludwig‐Mayerhofer, N. Erazo, Rolf R. Engel, Adelheid Czernik, H. Giedke, B. Müller‐Oerlinghausen, Michael Osterheider, G. A. E. Rudolf, Heinrich Sauer, J. Tegeler, Tilman Wetterling	53
15	Zur Normenäquivalenz von HAWIE-R und HAWIE. 1996 ·Diagnostica ·(unknown), (unknown), Rolf R. Engel	2
16	Carbon monoxide generation from hydrocarbons at ambient and physiological temperature: a sensitive indicator of oxidant damage? 1995 ·Journal of Chromatography A ·Michael D. Levitt, Carol Ellis, John Springfield, Rolf R. Engel	10
17	[Sleep behavior, personality and use of hypnotics in chronic primary insomnia (author's transl)]. 1980 ·PubMed ·Rolf R. Engel, (unknown)	2
18	Thyroid function in preterm infants with respiratory distress syndrome 1979 ·The Journal of Pediatrics ·(unknown), Rolf R. Engel	54
19	Necrotizing enterocolitis 1975 ·The Journal of Pediatrics ·Ivan D. Frantz, (unknown), Rolf R. Engel, Carl E. Hunt	94
20	FACTORS INFLUENCING PULMONARY METHANE EXCRETION IN MAN 1971 ·The Journal of Experimental Medicine ·John H. Bond, Rolf R. Engel, Michael Levitt	275

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact